• Sclerosing encapsulating peritonitis (SEP) is associated with the administration of beta-blocking agents as well as continuous ambulatory peritoneal dialysis. The predisposing factors in the latter group are recurrent peritonitis, presence of acetate in the dialysate, and antiseptics used during bag exchanges. We report a case of SEP following chronic ambulatory peritoneal dialysis and review the literature on this benign yet potentially lethal condition. Sclerosing encapsulating peritonitis frequently leads to intestinal obstruction, small-bowel necrosis, enterocutaneous fistulas, and malnutrition. There is a high incidence of anastomotic failure when a resection and primary intestinal anastomosis is performed in patients with SEP. Although SEP is not commonly reported in the surgical literature, its importance to surgeons is indicated by the fact that the overall mortality rate is close to 60% in patients with SEP who develop surgical complications.
(Arch Surg. 1990;125:1626-1628)
Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical Aspects of Sclerosing Encapsulating Peritonitis. Arch Surg. 1990;125(12):1626–1628. doi:10.1001/archsurg.1990.01410240108022
Customize your JAMA Network experience by selecting one or more topics from the list below.